19
2.37%
Incyte Announces U.S. FDA Approval of OpzeluraTM (ruxolitinib) Cream for the Treatment of Vitiligo FIRST EVER FDA APPROVED VITILIGO DRUG !!!
19
2.37%
Cost:
Manual Stats:
Include in groups:
Products: